.png?width=647&height=187&name=Biomarkers%20%26%20Precision%20Medicine%20US%202025%20(White).png "Biomarkers & Precision Medicine US 2025 (White)")
Anand Giddabasappa
Head of Animal Models and Imaging,
Pfizer Inc
Arpita Ray
Principal Scientist,
Genentech
Jean-Francois Martini
Executive Director, Translational Oncology Lead, Global Product Development, Oncology,
Pfizer
Kristina McGuire
Executive Director,
Regeneron
Kyuho Han
Chief Executive Officer,
MEDiC Life Sciences
Lokesh Agrawal
Program Director,
National Cancer Institute
Robert Getzenberg
Medical Director Diagnostics,
Astellas
Satya Saxena
Director, Global Proteomics, Clinical Pharmacology & Translational Medicine,
Eisai, Inc
Anshu Agrawal
Professor,
University of California, Irvine
.jpg?length=600&name=Shrivastav%20Pic%20(2).jpg)
Anuraag Shrivastav
President,
Oncodrex
David Weingeist
Scientific Director,
Johnson & Johnson
Jadwiga Bienkowska
Senior Director,
Pfizer
Jonathan Sims
Senior Director,
Eli Lilly and Company
Joseph McDermott
Computational Biologist,
Lantern Pharma
KC Hart
Clinical Biomarker Lead,
IGM Biosciences
Manoj Kandpal
Director of Research Bioinformatics,
Rockefeller University
Matthias von Herrath
Vice President & Senior Medical Officer, Global Chief Medical Office,
Novo Nordisk
.jpg?length=600&name=Rawan%20Tarawneh_headshot%202024%20(1).jpg)
Rawan Tarawneh
Associate Professor, School of Medicine, Department of Neurology,
University of New Mexico
Ruchi Gupta
Head of Biomarkers,
Alector Inc.
Soumya Poddar
Associate Director, Translational Sciences,
Gilead Sciences
Sripad Ram
Digital Pathology and Image Analysis Lead,
Pfizer Inc
Vitalay Fomin
Chief Executive Officer,
Numenos
Xuemei Zhao
Senior Principal Scientist,
Merck & Co., Inc.
Yiming Zhu
Senior Director, Biomarker Sciences,
Avidity Biosciences
.png?length=600&name=046426c9-c3ad-4603-90e6-6a47d97458a6-2-5668375logo-Azenta_Logo_Primary_FullColor_BlackType_RGB-(2).png){kind=logo}
.png?length=600&name=23c79081-69ce-4042-a188-0a0e10023652-2-5668375logo-Hawk-(RGB-Full-Colour).png)
.png?length=600&name=Zifo_Master%20Logo_Two%20colour_RGB%20(002).png)
Meet Our Esteemed Sponsors
Network & Programme Sponsors
Sponsors of Biomarkers US 2024 included
10x Genomics
Gold Sponsor
Building a complete understanding of the vast complexities of biology, from single cells to tissues and beyond, requires multiomic approaches. At 10x Genomics, we provide single cell, spatial, and in situ technologies that fuel scientific discoveries and drive exponential progress. Uncover molecular insights, dissect cell-type differences, detect novel cell subtypes and biomarkers, define gene regulatory interactions, and decipher spatial gene expression patterns.
Almac Diagnostic Services
Network & Programme Sponsor
Almac Diagnostic Services support global pharma and biotech companies with their biomarker strategies from biomarker discovery through to companion diagnostic partnerships. Almac has clinical and research laboratories in Europe and the USA, alongside strategic partnerships in China, enabling us to support global studies. The services offered fall into three main categories: Genomic Services, Clinical Trial Assays & Companion Diagnostics.
Biognosys
Bronze Sponsor
At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that transform science for better lives. With our versatile portfolio of next-generation proteomics solutions, including the TrueDiscovery®, TrueTarget®, and TrueSignature® research service platforms, our flagship software Spectronaut®, and the PQ500™ kit, we make the proteome actionable to empower research, drug development, and clinical decision-making. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Our unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins with industry-leading precision, depth, and throughput. Through our strategic partnership with Bruker (Nasdaq: BRKR), we make proteomics globally accessible. For more information, visit biognosys.com.
BioIVT
Network & Programme Sponsor
BioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to life science and diagnostic industries. Recognized as an industry leader, we specialize in control and disease state samples including human and animal tissues or preparations, cell and gene therapy products, blood, and other biofluids, as well as ADME contract research services from standalone bioanalytical support through tiered in vitro studies with submission-ready reports to customized consulting. By combining our technical expertise, exceptional customer service, and unmatched access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.
Canopy Biosciences®, a Bruker company
Silver Sponsor
Canopy Biosciences®, a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster. Our flagship CellScape™ Precise Spatial Multiplexing platform is a multiplex immunofluorescence imaging system for the whole-slide analysis of complex tissues and mapping of cell populations with single-cell resolution. Supported by Canopy Spatial Services, we provide a unique collection of spatial and single-cell technologies that accelerate the understanding of cellular diversity and interaction. Learn more at CanopyBiosciences.com.
CellCarta
Network & Programme Sponsor
Leading provider of specialized precision medicine laboratory services with integrated platforms in immunology, histopathology, proteomics, genomics, and related specimen collection and logistics services. CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials, and operates globally with laboratories in Canada, USA, Belgium, Australia, and China.
Crown Bioscience
Network & Programme Sponsor
Crown Bioscience, a JSR Life Sciences company, is a global CRO specializing in oncology drug discovery and development. It offers a range of preclinical and translational research services, including in vivo, in vitro, and ex vivo methodologies. The company supports drug development from discovery through clinical trials, with a diverse portfolio of oncology and immuno-oncology platforms and services for preclinical and translational research, complemented by multi-omics biomarker assays and bioanalytical services. With the acquisition of Indivumed Services, Crown Bioscience has expanded its biobank of human and liquid biospecimens linked to clinical data. It operates globally across the US, Europe, and APAC, with CAP and ISO-accredited labs.
Firalis Molecular Precision
Network & Programme Sponsor
Firalis Molecular Precision is a One-stop-shop CRO/CDMO equipped with high throughput Multi-Omics technologies dedicated to serve Biotech, Pharma, Academic Research and Health Organizations. Operating in 2 offices (Huningue, France in the heart of the BioValley and Cambridge, USA), Firalis Molecular Precision has a global team of 40+ efficient and reliable experts who have the appropriate knowledge and scientific expertise to understand your critical needs and provide robust trial. Inside its high qualified environment labs, Firalis Molecular Precision offers Multi-omics bioanalytical testing (genomics, transcriptomics, proteomics, lipidomics, metabolomics), biobanking infrastructure, assay development, data analysis and production facilities. Besides, as CDMO, Firalis Molecular Precision boasts a decade-long track record in the Assay-Development and Production sector, dedicated to overseeing the entire spectrum of processes crucial for obtaining CE marking and/or FDA approval for your products. Firalis’ Group certifications : ISO 9001:2015 (certification n° 2014/58992.7) : Quality management system; ISO 14001:2015 (certification n° 2022/100533.1) : Environmental management; ISO 13485:2016 (certification n° 2014/58993.6) : Development and production of immunoassays; ISO 20387 (certification n° 2016/71433.2) : Biobanking for research ; ISO 17025 :2017 (accreditation number n°8-3139) : testing activities. Firalis Molecular Precision is since end of August 2023 accredited by the CAP (College of American Pathologists).
Genseq
Network & Programme Sponsor
Genseq provides advanced genomics solutions to the biopharma and clinical sectors worldwide. Operating from our ISO 15189 and CAP-accredited laboratory in Dublin, and equipped with state-of-the-art sequencing platforms, our highly experienced team consistently generates high quality multiomic data at scale to meet our customers’ diverse project goals. Genseq’s comprehensive range of laboratory services includes next-generation sequencing, single cell sequencing, microarrays, gene panel testing, non-invasive prenatal screening, bioinformatic analysis, biobanking and sample management. The data generated at Genseq has a broad range of applications ranging from diagnostics to biomarker identification and patient stratification for clinical trials. From sample receipt to data analysis, Genseq take care to maximise the potential of every sample, every time.
Hologic Diagenode
Bronze Sponsor
Hologic Diagenode is a premier global provider of comprehensive solutions for epigenomics profiling services and sample preparation products tailored for next-generation sequencing, proteomics, and epigenetics research. We offer experimentally validated, user-friendly solutions and services for RNA, DNA, chromatin, and protein analysis, empowering researchers with the confidence and success needed to achieve exceptional results.
-(2).jpg?length=600&name=67212c21-4dc2-402c-ad6a-e8051e2c38f8-2-5668375logo-Company-Logo-1-(Biomarkers-UK)-(2).jpg){kind=logo}
Inoviv
Network & Programme Sponsor
Inoviv delivers comprehensive, fully quantitative, and validated LC-MS biomarker solutions designed to accelerate clinical strategy. With decades of experience in discovery and targeted LC-MS proteomics workflows, our assays offer exceptional throughput, specificity, precision, and accuracy for regulatory submissions. We provide both custom-designed and pre-validated IP-MS and LC-MS assays for target identification, mechanism-of-action studies, and disease staging across various sample types, including biofluids, tissues, cell lysates, and more. Our bioinformatics expertise also enables biomarker selection support from exploratory studies, focusing on insightful discovery rather than data overload. Visit www.inoviv.com to schedule a meeting with our experts and discover how we can help accelerate your drug development goals.
LevitasBio
Gold Sponsor
LevitasBio’s mission is to advance science and human health by providing researchers with a powerful, new method of cellular analysis. The last decade has seen tremendous advancement in analytical tools for genomics and proteomics such as next-generation sequencing, single cell genomics, and even phenotypic imaging down to single-cell resolution;but there has been no innovation in the sample preparation and cellular analysis market for decades – until now. We offer the first truly novel advancement in cellular analysis in 30 years. Our proprietary label-free Levitation Technology™ enables researchers to rescue and achieve higher quality and quantity of cells without introducing bias, high pressure, and modifications to gene expression profiles, ensuring the integrity of downstream data and analysis is maintained. The LeviCell® platform offers a revolutionary workflow in simplicity, speed, and reproducibility. Unlike traditional cell enrichment methods, it only requires 3 hands-on steps and has a 20-minute run from start to finish.
Lunaphore Technologies S.A. – a Bio-Techne brand
Silver Sponsor
Lunaphore Technologies S.A. – a Bio-Techne brand, is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit https://lunaphore.com.
Mission Bio
Silver Sponsor
Mission Bio specializes in the widespread adoption of single-cell DNA and multi-omic analysis. The Tapestri Platform is currently enabling advancements in cancer research, drug development, and cell and gene therapy, where understanding genetic heterogeneity at the single-cell level is crucial. This technology has the potential to lead to more personalized and effective treatment strategies. The level of precision and resolution provided is not easily achievable by combining bulk sequencing and other traditional methods.
MLM Medical Labs
Network & Programme Sponsor
MLM Medical Labs is a renowned central and specialty laboratory that operates globally, with a strong presence in Europe and North America. With a team of over 200 proficient and experienced professionals, MLM supports over 300 clinical studies concurrently. The company offers a vast array of services, including central lab testing, specialized and bespoke testing, histology, analysis of biomarkers, preclinical services, assay development, kit building, and long-term sample management and storage. MLM is headquartered in Mönchengladbach, Germany, near Düsseldorf, and has additional branches located in Memphis, TN, and Minneapolis, MN, in the USA. To learn more about MLM Medical Labs, please visit their website at, www.mlm-labs.com.
Olink
Silver Sponsor
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways. Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base. For more information visit www.olink.com.
Rules-Based Medicine (RBM), an IQVIA business
Network & Programme Sponsor
Rules-Based Medicine (RBM), an IQVIA business, is a leading multiplexed immunoassay testing laboratory offering internally developed multi-analyte profiles (MAPs) on the Luminex platform and ultrasensitive Simoa testing. RBM also performs the Olink Target 48 Cytokine panel with additional Olink testing coming soon. RBM provides reproducible and quantitative data for 300+ immunoassays, which provides extensive coverage of numerous pathways and delivers accurate pharmacodynamic and safety assessments from its CLIA-certified biomarker testing laboratory in Austin, TX. RBM also has a novel whole blood immunophenotyping device (TruCulture®). TruCulture enables researchers to reproducibly ascertain information about immune responses to stress or stimulation, including responses to novel therapeutics.
Sapient
Silver Sponsor
Sapient is a biomarker discovery organization providing bespoke services for metabolomics, lipidomics, and proteomics data generation and analysis, enabling biopharma sponsors to go beyond the genome to accelerate precision drug development. Using state-of-the-art, high-throughput mass spectrometry technologies, Sapient enables nontargeted multi-omics measurements to capture thousands of dynamic biomarkers in human, preclinical, and cellular biosamples, across thousands of samples at a time. These technologies are leveraged within a larger discovery infrastructure that includes a comprehensive biocomputational framework for analysis of large-scale, multi-omics data;robust quality control analysis;and mapping of key biomarker-phenotype associations. Sapient can cross-validate discoveries using our proprietary in-house longitudinal Human Biology Database that includes data from over 100,000 human biosamples with paired phenotypic measures. Together our approaches enable rapid identification, validation, and translation of dynamic biomarkers of biological processes, disease mechanisms, and drug response across all drug development phases.
Sengenics
Silver Sponsor
Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.
SomaLogic
Gold Sponsor
Standard BioTools Inc., the parent company of SomaLogic Inc. and previously known as Fluidigm, equips the life science industry with a unique suite of innovative and reliable multi-omic technologies that enable researchers to boldly explore life sciences challenges that advance human health. A pioneering technology, the SomaScan® Platform profiles 11,000 protein measurements, ideal for biomarker discovery. The SomaScan Assay provides researchers with the ability to measure thousands of proteins simultaneously, delivering unparalleled protein coverage and precision. This platform is vital for advancing biomarker discovery, accelerating the development of diagnostic tools and gaining deeper insights into complex biological systems.
